Herbas VPB

Print
EN | LT
LT - AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
EN - AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/485
A61K 31/555
A61K 31/675
A61K 31/7068
A61K 45/06
A61P 35/00
G01N 33/50
European patent
(11) Number of the document 3600433
(13) Kind of document T
(96) European patent application number 18717108.7
Date of filing the European patent application 2018-03-28
(97) Date of publication of the European application 2020-02-05
(45) Date of publication and mention of the grant of the patent 2021-05-05
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/GB2018/050843
Date 2018-03-28
PCT application publication
(87) Number WO 2018/178690
Date 2018-10-04
Priority applications
(30) Number Date Country code
201704910 2017-03-28 GB
201718806 2017-11-14 GB
Inventors
(72)
DALGLEISH, Angus, GB
LUI, Wai, GB
Grantee
(73) LDN Pharma Limited, 25 Moorgate, London, EC2R 6AY, GB
Title
(54) AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
  AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
Last update date 2021-08-11